about
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated thro...
Read More
344.92
5.04
(1.48%)
788.6K
XNAS Volume
XNAS 02 Sep, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Insulet Corporation is on 09 Sep 2025 for the purpose of Baird 2025 Global Healthcare Conference
See details
High Financial Strength
Expensive Valuation
Technically Moderately Bullish
Expensive Star
These stocks are bullish in nature, strong in quality and technical aspects, but bad in valuations. Investors need to be cautious on their returns earned.
View Similar
Embed DVM
Insulet Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..